RP-182 acetate
Based on 1 Customer Validation
RP-182 acetate is a synthetic immunomodulatory peptide that exerts anti-tumor effects by targeting the mannose receptor CD206 (Kd = 8 μM) on the surface of tumor-associated macrophages (TAMs). RP-182 acetate induces a conformational switch of the CD206 receptor, which activates NF-κB signaling and phagocytosis in CD206high TAMs. RP-182 acetate has dual function: activation of canonical NF-κB signaling, triggering TNFα secretion and autocrine activation of the TNF receptor 1 (TNFR1), leading to activation of caspase 8, apoptosis, and cell death. RP-182 acetate is used in pancreatic cancer and melanoma research.
For research use only. We do not sell to patients.
- Formula: C69H103N19O11·xC2H4O2
- Molecular Weight:1374.68 (free base)
-
Storage:
Sealed storage, away from moisture.
Powder -80°C, 2 years , -20°C, 1 year* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
All Caspase Isoforms
More
Biological Activity
RP-182 acetate (1 nM-1 mM, 48 h) increases cell killing of CD206high M2-like macrophages with an IC50 of 17.6 μM through the MyD88/NF-κB pathway[1][2].
RP-182 acetate (0.1 μM, 2-24 h) internalizes CD206, activated NF-κB, and increased IRF7 phosphorylation in IL-4-polarized M2 bone marrow-derived macrophages[1][2].
RP-182 acetate (3-30 μM, 24 h) increases levels of inflammatory factors secreted by macrophages, indicating immune reprogramming[1][2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:Macrophages
-
Concentration:3, 10 and 30 μM
-
Incubation Time:24 h
-
Result:Increased the levels of TNFα and IFNγ.
RP-182 acetate (20 mg/kg, i.p., once daily for 18 days) significantly alleviates pulmonary fibrosis in mice[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:B16 melanoma allograft and KP16 pancreatic model established in eight- to twelve-week old C57B/L6 mice[1]
-
Dosage:20 mg/kg
-
Administration:Intraperitoneal injection (i.p.), every other day for 2 weeks
-
Result:Inhibited tumor growth and prolonged median survival in mice
Increased CD8+ T cell infiltration.
Significantly increased IFN-γ secretion by CD8+ T cells in tumors.
-
Animal Model:B16 melanoma allograft and KP16 pancreatic model established in eight- to twelve-week old C57B/L6 mice[1]
-
Dosage:20 mg/kg
-
Administration:Intraperitoneal injection (i.p.), every other day for 2 weeks
-
Result:Inhibited tumor growth and prolonged median survival in mice
Increased CD8+ T cell infiltration.
Significantly increased IFN-γ secretion by CD8+ T cells in tumors.
Chemical Information
-
Appearance Solid
-
Molecular Weight 1374.68 (free base)
-
Formula C69H103N19O11·xC2H4O2
-
Sequence
Lys-Phe-Arg-Lys-Ala-Phe-Lys-Arg-Phe-Phe
-
Sequence Shortening
KFRKAFKRFF
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Sealed storage, away from moisture
Powder -80°C 2 years -20°C 1 year * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Solvent & Solubility
H2O : ≥ 100 mg/mL
* "≥" means soluble, but saturation unknown.
Purity & Documentation
-
Data Sheet (275 KB)
-
SDS (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)